Chimeric fusion proteins, produced by genetic engineering, are currently made up of effector peptides, for example, a ligand-binding portion of a cytokine or growth factor, extracellular domains of lymphocyte antigens, or a toxin linked to a suitable fusion partner.
This report contains market size and forecasts of Chimeric Fusion Protein in Global, including the following market information:
Global Chimeric Fusion Protein Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chimeric Fusion Protein market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Etanercept Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chimeric Fusion Protein include Astellas Pharma, Regeneron, Amgen, Ligand Pharmaceuticals, Bristol-Myers Squibb, Viventia and Genzyme, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chimeric Fusion Protein companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chimeric Fusion Protein Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chimeric Fusion Protein Market Segment Percentages, by Type, 2021 (%)
Etanercept
Belatacept
Abatacept
Alefacept
Others
Global Chimeric Fusion Protein Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chimeric Fusion Protein Market Segment Percentages, by Application, 2021 (%)
Autoimmune
Tumor
Others
Global Chimeric Fusion Protein Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chimeric Fusion Protein Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chimeric Fusion Protein revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chimeric Fusion Protein revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma
Regeneron
Amgen
Ligand Pharmaceuticals
Bristol-Myers Squibb
Viventia
Genzyme